搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Woman's World on MSN
4 小时
Dealing with a Blocked Nostril? Here’s How to Clear It Fast!
Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...
health enews
2 天
Nasal congestion on one side? You may have this condition
A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.
14 小时
on MSN
Battling Sinus Woes? Here’s How Seasonal Allergies Can Wreak Havoc and What You Can Do ...
Expert says, that by recognising the connection between seasonal changes, allergies, and sinus health, individuals can take ...
Monthly Prescribing Reference
1 天
Tezspire Reduces Nasal Congestion and Polyp Size in Chronic Rhinosinusitis
Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...
Onlymyhealth
4 天
From Allergies to Asthma, These Conditions Can Trigger Nasal Polyps
often resulting from chronic inflammation. While these benign growths themselves are not harmful, they can lead to ...
19 小时
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
Woman's World on MSN
1 天
Is Your Toothache Actually a Sinus Infection? How to Tell—and Treat It
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
FiercePharma
10 小时
AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study
A phase 3 study has shown that when compared with placebo, Tezspire provided a statistically significant and clinically ...
13 小时
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...
14 小时
on MSN
Amgen, AstraZeneca post Phase 3 win for nasal polyps therapy
Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...
12 小时
Amgen, AstraZeneca announce top-line results from WAYPOINT trial
Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...
8 小时
AstraZeneca announces WAYPOINT trial met both co-primary endpoints
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈